22048 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Aug 13
00:18 UTC
|
MAU
Montage Gold
|
◎ Target | firm only | Sec→ r Outperform | C$19.00→ C$20.00+5.3% |
|
Aug 13
00:18 UTC
|
MAU
Montage Gold
|
◎ Target | firm only | Outperform | C$19.00→ C$22.00+15.8% |
|
Aug 13
00:18 UTC
|
MASS
908 Devices
|
◎ Target | Daniel Arias ★★★★★ #216 | Buy | $10.00→ $12.00+20.0% |
|
Aug 13
00:18 UTC
|
MASS
908 Devices
|
◎ Target | Max Masucci not yet tracked | Buy | $11.00→ $13.00+18.2% |
|
Aug 13
00:18 UTC
|
MAA
Mid-America Apartment Communities
|
◎ Target | Adam Kramer ★★★☆☆ #1432 | Overweight | $155.00→ $147.00-5.2% |
|
Aug 13
00:18 UTC
|
LQDA
Liquidia
|
◎ Target | Julian Harrison ★★★☆☆ #2075 | Buy | $109.00→ $111.00+1.8% |
|
Aug 13
00:18 UTC
|
LQDA
Liquidia
|
◎ Target | Serge Belanger ★★★☆☆ #1179 | Buy | $70.00→ $110.00+57.1% |
|
Aug 13
00:18 UTC
|
LOW
Lowe's Companies
|
◎ Target | Steven Shemesh ★★★☆☆ #1453 | Sec→ r Perform | $232.00→ $231.00-0.4% |
|
Aug 13
00:18 UTC
|
LITE
Lumentum
|
◎ Target | Sean O'Loughlin ★★★☆☆ #1683 | Hold | $800.00→ $820.00+2.5% |
|
Aug 13
00:18 UTC
|
LITE
Lumentum
|
◎ Target | Joseph Cardoso ★☆☆☆☆ #2981 | Overweight | $1,165.00→ $1,280.00+9.9% |
|
Aug 13
00:18 UTC
|
LITE
Lumentum
|
◎ Target | Vivek Arya ★★☆☆☆ #2489 | Neutral | $1,100.00→ $1,000.00-9.1% |
|
Aug 13
00:18 UTC
|
LITE
Lumentum
|
◎ Target | Meta Marshall ★★★★☆ #888 | Equal Weight | $900.00→ $1,000.00+11.1% |
|
Aug 13
00:18 UTC
|
LITE
Lumentum
|
◎ Target | Vijay Rakesh ★★☆☆☆ #2219 | Outperform | $1,100.00→ $1,140.00+3.6% |
|
Aug 13
00:18 UTC
|
LENZ
LENZ Therapeutics
|
◎ Target | Biren Amin ★★☆☆☆ #2801 | Neutral | $12.00→ $7.00-41.7% |
|
Aug 13
00:18 UTC
|
LEGN
Legend Biotech
|
◎ Target | Matthew Harrison not yet tracked | Overweight | $48.00→ $49.00+2.1% |
|
Aug 13
00:18 UTC
|
LEGN
Legend Biotech
|
◎ Target | Leonid Timashev ★★★★☆ #933 | Outperform | $59.00→ $58.00-1.7% |
|
Aug 13
00:18 UTC
|
LEGN
Legend Biotech
|
◎ Target | Yaron Werber ★★★☆☆ #2091 | Hold | $29.00→ $24.00-17.2% |
|
Aug 13
00:18 UTC
|
LEGN
Legend Biotech
|
◎ Target | Etzer Darout ★★★☆☆ #1620 | Overweight | $80.00→ $78.00-2.5% |
|
Aug 13
00:18 UTC
|
LEG
Leggett & Platt
|
◎ Target | Peter Keith ★★★☆☆ #1074 | Neutral | $12.00→ $10.00-16.7% |
|
Aug 13
00:18 UTC
|
LDOS
Leidos
|
◎ Target | Gavin Parsons ★★★☆☆ #1266 | Neutral | $152.00→ $132.00-13.2% |
|
Aug 13
00:18 UTC
|
LBRX
LB Pharmaceuticals
|
◎ Target | Malcolm Hoffman not yet tracked | Outperform | $46.00→ $54.00+17.4% |
|
Aug 13
00:18 UTC
|
LAR
Lithium Americas (Argentina)
|
◎ Target | Ben Isaacson ★★★☆☆ #1258 | Sec→ r Outperform | $10.00→ $9.50-5.0% |
|
Aug 13
00:18 UTC
|
LAMR
Lamar Advertising
|
◎ Target | Steven Cahall ★★★☆☆ #1139 | Equal Weight | $150.00→ $151.00+0.7% |
|
Aug 13
00:18 UTC
|
KSPI
Joint Stock Company Kaspi.kz
|
◎ Target | James Friedman ★★★☆☆ #978 | Neutral | $95.00→ $100.00+5.3% |
|
Aug 13
00:18 UTC
|
KRNT
Kornit Digital
|
◎ Target | James Ricchiuti ★★★☆☆ #1237 | Buy | $22.00→ $23.00+4.5% |
|
Aug 13
00:18 UTC
|
KNTK
Kinetik
|
◎ Target | Gabe Daoud not yet tracked | Buy | $53.00→ $59.00+11.3% |
|
Aug 13
00:18 UTC
|
JRVR
James River Group
|
◎ Target | Mark Hughes ★★★☆☆ #1349 | Hold | $6.00→ $5.00-16.7% |
|
Aug 13
00:18 UTC
|
JBS
JBS
|
◎ Target | Lucas Ferreira ★★☆☆☆ #2762 | Overweight | $18.00→ $17.50-2.8% |
|
Aug 13
00:18 UTC
|
JBI
Janus International Group
|
◎ Target | John Lovallo ★★★☆☆ #1185 | Neutral | $6.00→ $5.60-6.7% |
|
Aug 13
00:18 UTC
|
IPI
Intrepid Potash
|
◎ Target | Joshua Spector ★★★☆☆ #1538 | Sell | $26.00→ $29.00+11.5% |
|
Aug 13
00:18 UTC
|
IPHA
Innate Pharma
|
◎ Target | Jeet Mukherjee ★★★☆☆ #1257 | Buy | $8.00→ $9.00+12.5% |
|
Aug 13
00:18 UTC
|
INTC
Intel
|
◎ Target | Timothy Arcuri ★★★☆☆ #1816 | Neutral | $121.00→ $112.00-7.4% |
|
Aug 13
00:18 UTC
|
INF
Informa
|
◎ Target | firm only | Buy | GBX 990→ GBX 1,090+10.1% |
|
Aug 13
00:18 UTC
|
IMNM
Immunome
|
◎ Target | Supawat Thongthip not yet tracked | Buy | $37.00→ $38.00+2.7% |
|
Aug 13
00:18 UTC
|
IMNM
Immunome
|
◎ Target | David Nierengarten ★★★☆☆ #1115 | Outperform | $31.00→ $35.00+12.9% |
|
Aug 13
00:18 UTC
|
IAG
Iamgold
|
◎ Target | Tanya Jakusconek ★★★☆☆ #1559 | Sec→ r Perform | $22.00→ $23.00+4.5% |
|
Aug 13
00:18 UTC
|
HRB
H&R Block
|
◎ Target | Alexander Paris ★★★☆☆ #2005 | Outperform | $50.00→ $60.00+20.0% |
|
Aug 13
00:18 UTC
|
HRB
H&R Block
|
◎ Target | George Kelly ★★★☆☆ #1264 | Sell | $29.00→ $33.00+13.8% |
|
Aug 13
00:18 UTC
|
HPQ
HP
|
◎ Target | Michael Ng not yet tracked | Sell | $19.00→ $21.00+10.5% |
|
Aug 13
00:18 UTC
|
HMH
HMH
|
◎ Target | Stephen Gengaro ★★★☆☆ #1942 | Buy | $27.00→ $28.00+3.7% |
|
Aug 13
00:18 UTC
|
HLIO
Helios Technologies
|
◎ Target | Nathan Jones ★★★☆☆ #1947 | Buy | $93.00→ $95.00+2.2% |
|
Aug 13
00:18 UTC
|
HLIO
Helios Technologies
|
◎ Target | Tomohiko Sano ★★★☆☆ #997 | Overweight | $100.00→ $110.00+10.0% |
|
Aug 13
00:18 UTC
|
HIK
Hikma Pharmaceuticals
|
◎ Target | firm only | Buy | GBX 1,700→ GBX 1,870+10.0% |
|
Aug 13
00:18 UTC
|
HG
Hamilton Insurance Group
|
◎ Target | Tommy McJoynt not yet tracked | Outperform | $39.00→ $40.00+2.6% |
|
Aug 13
00:18 UTC
|
HD
Home Depot
|
◎ Target | Steven Shemesh ★★★☆☆ #1453 | Sec→ r Perform | $340.00→ $343.00+0.9% |
|
Aug 13
00:18 UTC
|
HBT
HBT Financial
|
◎ Target | firm only | Outperform | $40.00→ $44.00+10.0% |
|
Aug 13
00:18 UTC
|
HBIO
Harvard Bioscience
|
◎ Target | Bruce D. Jackson not yet tracked | Speculative Buy | $6.00→ $7.50+25.0% |
|
Aug 13
00:18 UTC
|
GPMT
Granite Point Mortgage Trust
|
◎ Target | Jade Rahmani ★★★★☆ #841 | Market Perform | $1.50→ $1.25-16.7% |
|
Aug 13
00:18 UTC
|
GLEN
Glencore
|
◎ Target | firm only | Buy | GBX 770→ GBX 780+1.3% |
|
Aug 13
00:18 UTC
|
GEN
Genuit Group
|
◎ Target | firm only | Overweight | GBX 440→ GBX 450+2.3% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.